Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CMPI | AZN | AMGN | GILD | BMY |
| Company | Checkmate Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.49 | 183.80 | 336.44 | 133.89 | 57.60 |
| High | 10.50 | 185.85 | 337.95 | 135.95 | 57.69 |
| Low | 10.48 | 183.36 | 334.16 | 132.79 | 56.26 |
| Latest | 10.50 | 185.98 | 336.32 | 135.53 | 56.83 |
| Change | +0.02 | +0.33 | +0.26 | +1.84 | -0.69 |
| % Change | +0.19% | +0.18% | +0.08% | +1.38% | -1.20% |
| Volume | 63,600 | 1,190,390 | 999,029 | 2,677,676 | 7,398,539 |
| 20-Day Average Volume | 283,120 | 1,815,560 | 2,650,297 | 5,981,141 | 10,340,134 |
| Previous Close | 10.48 | 185.65 | 336.06 | 133.69 | 57.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.43 | 184.96 | 332.92 | 132.62 | 57.51 |
| 20-Day Raw Stochastic | 100.00% | 50.09% | 55.58% | 81.29% | 30.14% |
| 20-Day Relative Strength | 87.35 | 46.17 | 47.81 | 52.45 | 46.13 |
| Weighted Alpha | -59.50 | +22.72 | +14.07 | +21.09 | +18.66 |
| Today's Opinion | 100% Buy | 8% Sell | 8% Sell | 24% Buy | Hold |
| Previous Opinion | 100% Buy | 8% Sell | 8% Sell | 8% Buy | 16% Buy |
| Last Month's Opinion | 88% Buy | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.38% since 05/20/22 | -0.91% since 05/20/26 | +1.53% since 05/20/26 | +3.84% since 05/20/26 | -2.59% since 05/20/26 |
| Low | 10.47 on 05/23/22 | 183.35 on 05/28/26 | 329.09 on 05/21/26 | 129.42 on 05/21/26 | 56.26 on 05/28/26 |
| High | 10.50 on 05/27/22 | 191.50 on 05/21/26 | 343.80 on 05/22/26 | 136.32 on 05/26/26 | 60.25 on 05/22/26 |
| 1-Month | |||||
| %Chg | +1.06% since 04/27/22 | -0.49% since 04/28/26 | -0.86% since 04/28/26 | +4.99% since 04/28/26 | -2.12% since 04/28/26 |
| Low | 10.34 on 05/11/22 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.96 on 04/30/26 | 55.40 on 05/11/26 |
| High | 10.50 on 05/27/22 | 191.50 on 05/21/26 | 349.54 on 04/30/26 | 137.50 on 05/12/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +268.42% since 02/25/22 | -10.89% since 02/27/26 | -13.27% since 02/27/26 | -8.89% since 02/27/26 | -8.57% since 02/27/26 |
| Low | 2.41 on 04/18/22 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 10.50 on 05/27/22 | 207.30 on 04/10/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +193.30% since 11/26/21 | +0.17% since 11/28/25 | -2.55% since 11/28/25 | +7.85% since 11/28/25 | +15.90% since 11/28/25 |
| Low | 2.00 on 01/27/22 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 48.22 on 12/02/25 |
| High | 10.50 on 05/27/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 231,399 | 287,926,048 | 181,374,272 | 165,985,488 | 117,459,928 |
| Shares Outstanding, K | 22,038 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -61,410,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -15,870,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | -4.84 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/12/22 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/11/22 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.21 | 15.20 | 15.98 | 9.79 |